Inactive Instrument

Quotes Catalyst Biosciences Inc Nasdaq

Stocks

End-of-day quote Nasdaq
- ^USD	-

25-06-16	Crescent Biopharma Completes Merger With GlycoMimetics	MT
23-10-30	Catalyst Biosciences, Inc.(NasdaqCM:CBIO) dropped from NASDAQ Composite Index	CI

Stock exchange

Nasdaq- $ - 0 $

Markets		Price	Change	Volumes
Nasdaq	CBIO	6.590USD	-1.35%	284K $
Deutsche Boerse AG	HGF2	5.700EUR	0.00%	0 €

Market Cap (USD)

19,418,220

Net sales ()

794,000

Date	Opening	High	Low	Close	Volume	Change

Duration

Period